Generic Drugs Market Forecast 2018-2028 - Visiongain Report

LONDON, May 3, 2018 /PRNewswire/ --

Growth in Leading Regional and National Markets - North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America, US, Canada, Germany, France, UK, Italy, Spain, India, China, Australia, South Korea, Japan, South Africa, Saudi Arabia, U.A.E, Brazil, Argentina, Mexico

     (Logo: Logo: http://mma.prnewswire.com/media/523989/Visiongain_Logo.jpg )

Report Details 

The generic drugs market is estimated at $257.3bn in 2017 and is expected to grow at a CAGR of 7.9% from 2017 to 2028. The generic drugs market is expected to grow at a CAGR of 7.2% in the second half of the forecast period.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 254-page report  you will receive 66 tables and 84 figures- all unavailable elsewhere.

The 254-page report provides clear detailed insight into the generic drugs market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope 

• Generic Drugs Market forecasts  from 2018-2028

• Generic Drugs Regional Market and National Market forecasts from 2018-2028, covering:
• North America: US & Canada
• Europe: Germany, UK, France, Italy, Spain, Rest of Europe
• Asia-Pacific: Japan, Australia, India, China, South Korea, Rest of Asia-Pacific
• Middle East & Africa: South Africa, Saudi Arabia, U.A.E, Rest of Middle East & Africa
• Latin America: Brazil, Argentina, Mexico, Rest of Latin America

• SWOT Analysis and Porter's Five Forces Analysis of the generic drugs market.

• Assessment of selected leading companies that hold major market shares in the generic drugs market.
• Teva
• Novartis (Sandoz)
• Allergan
• Mylan
• Pfizer
• Abbott
• Sun Pharma
• Aspen
• Fresenius Kabi
• Sanofi
• Dr. Reddy's Laboratories
• Apotex

Visiongain's study is intended for anyone requiring commercial analyses for the Generic Drugs Market. You find data, trends and predictions.

Buy our report today Generic Drugs Market Forecast 2018-2028: Growth in Leading Regional and National Markets - North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America, US, Canada, Germany, France, UK, Italy, Spain, India, China, Australia, South Korea, Japan, South Africa, Saudi Arabia, U.A.E, Brazil, Argentina, Mexico.

To request a report overview of this report please email Sara Peerun at [email protected] or call Tel: +44-(0)-20-7336-6100

Or click on: https://www.visiongain.com/Report/2179/Generic-Drugs-Market-Forecast-2018-2028

List of Companies Mentioned in the Report 

Abbott

AbbVie

Able Laboratories

Aché

Actavis

Alcon (Novartis)

Allergan (Actavis)

Amgen

Anda Inc

Apotex

APP Pharmaceuticals

Arrow Group (Actavis)

Ascent Pharmahealth (Actavis)

ASKA Pharmaceuticals

Aspen

AstraZeneca

Aurobindo

Auspex Pharmaceuticals

Bedford Laboratories

Bergamo (Amgen)

Biocon

Bioniche Pharma (Mylan)

BMP Sunstone (Sanofi)

Caraco

Celltrion

CFR Pharmaceuticals (Abbott)

Cipla

Claris

Dabur Pharma (Fresenius Kabi)

Daiichi Sankyo

Dalim BioTech

Dr Reddy's Laboratory

Ebewe Pharma (Novartis)

Eden Biopharm Group

Egis

Elder Pharmaceuticals (Torrent Pharmaceuticals)

Eli Lilly

Elyson Pharmaceuticals

EMS Sigma Pharma

Eon Labs

Eurofarma Laboratories

Farmacias Similares

Fenwal (Fresenius Kabi)

Forest Laboratories (Actavis)

Foshan Chanbende Development

Fougera Pharmaceuticals (Novartis)

Fresenius Kabi

Fresenius SE & Co

Fuji Pharma

Gavis Pharmaceuticals

Gedeon Richter

Genfar S.A (Sanofi)

Genzyme (Sanofi)

Gilead Sciences

GlaxoSmithKline (GSK)

Greenstone (Pfizer)

Grupo Sanborns

Grupo Uriach

Hexal

Hospira (Pfizer)

IDEV Technologies (Abbott)

Ilsung Pharmaceuticals

Imperial Credit Private Limited

InnoPharma Inc

Itero Biopharmaceuticals

Janssen

Javelin Pharmaceuticals (Hospira)

Johnson & Johnson

Kmart

KMS Pharmaceutical

Kowa Pharmaceuticals

Krka

Labesfal Genéricos (Fresenius Kabi)

Laboratorio Sanderson (Fresenius Kabi)

Laboratorios Best

Laboratorios Kendrick (Sanofi)

Lek (Novartis)

Lundbeck

Lupin

Matrix Laboratories

Mayne Pharma (Hospira)

Meda AB

Medley (Sanofi)

Merck KGaA

MN Pharma (Amgen)

Momenta Pharmaceuticals

Mylan

Natco Pharma

Nexus Pharmaceuticals

Nichi-Iko

Nippon Chemiphar

Novartis (Sandoz)

Novo Nordisk

OptiMedica (Abbott)

Orchid Chemicals & Pharmaceuticals

Oriel Therapeutics (Novartis)

Parenteral Drugs India Ltd

Perrigo

Pfizer

Piramal (Abbott Laboratories)

Pliva (Teva)

PT Soho Global Health

Ranbaxy (Sun Pharmaceuticals)

Ratiopharm

Rimsa

Roche

Sabex (Novartis)

Sanofi

Sawai Pharmaceuticals

Schein Pharmaceutical (Actavis)

Servier

Shelys (Aspen)

Sigma Pharmaceuticals (Aspen)

Solvay Pharmaceuticals (Abbott)

Specifar Pharmaceuticals (Actavis)

St. Jude Medical

STADA Arzneimittel

Strides Arcolab

Sun Pharma

Synthon

Taiyo Pharmaceuticals

Takeda

Teuto Brasileiro (Pfizer)

Teva

The Laboratory of Analytical Services International Ltd

Towa

UDL Laboratories

Uteron Pharma (Actavis)

Valeant Pharmaceuticals

Wal-Mart

Warner Chilcott (Actavis)

Watson

Wockhardt

Wyeth (Pfizer)

Zentiva (Sanofi)

Zhejiang Chiral Medicine Chemicals Co. Ltd

Zhejiang Hisun Pharmaceutical

Zydus Cadila

To see a report overview please email Sara Peerun on [email protected]

SOURCE Visiongain